Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cytosolic arginine sensor for mTORC1 subunit 2 pseudogene (ENSG00000293687) is a DNA sequence that retains homology to the CASTOR2 gene but has acquired loss-of-function mutations (e.g., premature stop codons) that make it incapable of producing functional protein[2][5][7]. Pseudogenes like this can sometimes be transcribed and may participate in RNA-based regulatory mechanisms, such as acting as microRNA decoys or generating small interfering RNAs affecting their cognate genes[1][3][4]. However, they do not perform the direct functional roles of their ancestral genes and generally are not considered molecular targets in therapeutic contexts. Identification of pseudogenes can pose challenges for molecular biology experiments due to sequence similarity with the parent gene[7]. There is no evidence that this pseudogene plays a role in disease, drug interaction, or patient biomarker utility. ENSG00000293687 is a noncoding, nonfunctional pseudogene with homology to the CASTOR2 gene. It is not a receptor, enzyme, or druggable target and does not have direct therapeutic or diagnostic roles. The listing as a "target" is incorrect, and any biological influence would be mediated through indirect noncoding RNA-based gene regulation rather than conventional molecular mechanisms.
None applicable as a therapeutic target. Mechanisms such as microRNA decoy or RNA interference are general pseudogene functions, but not drug targetable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic arginine sensor for mTORC1 subunit 2 pseudogene.